FDA Notices, Guidances Should Reflect St. John's Wort Interaction - CHPA

Center for Drug Evaluation & Research health advisories and guidances should be amended to communicate potential interactions of St. John's wort with certain types of Rx drugs, CHPA tells FDA.

More from Archive

More from Pink Sheet